rs201150987
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001330078.2(NRXN1):c.2437C>T(p.Arg813Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,613,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001330078.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRXN1 | NM_001330078.2 | c.2437C>T | p.Arg813Cys | missense_variant | 13/23 | ENST00000401669.7 | NP_001317007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRXN1 | ENST00000401669.7 | c.2437C>T | p.Arg813Cys | missense_variant | 13/23 | 5 | NM_001330078.2 | ENSP00000385017.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000805 AC: 20AN: 248396Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134746
GnomAD4 exome AF: 0.000154 AC: 225AN: 1460998Hom.: 0 Cov.: 31 AF XY: 0.000140 AC XY: 102AN XY: 726766
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74286
ClinVar
Submissions by phenotype
Pitt-Hopkins-like syndrome 2 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 31, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 853 of the NRXN1 protein (p.Arg853Cys). This variant is present in population databases (rs201150987, gnomAD 0.02%). This missense change has been observed in individual(s) with neurodevelopmental disorders (PMID: 21424692, 33004838). This variant is also known as R813C. ClinVar contains an entry for this variant (Variation ID: 539874). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect NRXN1 function (PMID: 21424692). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 21, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 01, 2020 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 26, 2024 | PP3 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | This variant is associated with the following publications: (PMID: 21424692) - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 04, 2020 | The c.2557C>T (p.R853C) alteration is located in exon 14 (coding exon 13) of the NRXN1 gene. This alteration results from a C to T substitution at nucleotide position 2557, causing the arginine (R) at amino acid position 853 to be replaced by a cysteine (C). Based on data from the Genome Aggregation Database (gnomAD) database, the NRXN1 c.2557C>T alteration was observed in 0.01% (22/279786) of total alleles studied, with a frequency of 0.02% (21/127956) in the European (non-Finnish) subpopulation. This alteration has been reported heterozygous as c.2437C>T (p.R813C) once from a cohort of patients with nonsyndromic intellectual disability. Inheritance was not determined. This alteration was also reported heterozygous in a patient with global developmental delay, hypotonia, toe syndactyly, micrognathia, and dysmorphic features as well as in the patient's father who had delay, hearing abnormalities, and learning difficulties. However, the proband also had a 1.18 Mb duplication of unknown significance (Deciphering Developmental Disorders Study, 2015; Gauthier, 2011). This amino acid position is highly conserved in available vertebrate species. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
NRXN1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 12, 2023 | The NRXN1 c.2557C>T variant is predicted to result in the amino acid substitution p.Arg853Cys. Using an alternate transcript (NM_004801), this variant is also referred to in the literature as c.2437C>T (p.Arg813Cys aka R813C). This variant was reported in an individual with nonsyndromic intellectual disability (Supplementary Table 1, Gauthier et al. 2011. PubMed ID: 21424692). This variant was also identified in a large-scaler study analyzing risk genes for neurodevelopmental disorders, however limited data was provided (Supplementary Dataset 5, Wang et al. 2020. PubMed ID: 33004838). This variant was also identified in a Deciphering Developmental Disorders Study analyzing individuals with severe, undiagnosed, developmental disorders, however the variant was paternally inherited and the patient also carried a maternally inherited GLI2 variant (Supplementary Table 4, Deciphering Developmental Disorders Study. 2014. PubMed ID: 25533962). Of note, a functional study showed that this variant had similar function to that of controls (Gauthier et al. 2011. PubMed ID: 21424692). This variant is reported in 0.016% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-50733693-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at